# Syndax Pharmaceuticals Inc: Form 8-K, filed Dec 20, 2023

- Company: [Syndax Pharmaceuticals Inc](/companies/sndx.md) (CIK 1395937)
- Form: 8-K
- Filed: 2023-12-20
- Accepted by EDGAR: Dec 20, 2023, 08:40 ET
- Period: 2023-12-19
- Accession: 0000950170-23-071749
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1395937/000095017023071749/sndx-20231219.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1395937/000095017023071749/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1395937/000095017023071749/sndx-20231219.htm

Filed Dec 20, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-071749. Last ingested by Listed: Oct 30, 2026, 19:11 ET. No prices; not investment advice.